Psyma+Exevia Health

Psyma+Exevia Health specializes in customized market research and consulting for the pharmaceutical, medical technology, diagnostics, and dental sectors. The company was formed by the 2022 merger of Exevia GmbH and Psyma Health & CARE under the umbrella of Germany’s largest privately owned market research group. It offers expertise across all stages of product life cycles with a focus on both national and international healthcare markets[3][5][7].

The firm supports clients with communications research, concept development, patient experience studies, opportunity assessment for new products/services in healthcare markets[6]. It does not conduct clinical trials or drug development.

Leadership includes Bernd Wachter (CEO), Roland Herterich and Norbert Schell (Managing Directors), Cornelia Wagner and Krish Guckenberger[5][6].

Headquarters are near Nuremberg with operations spanning multiple countries.

No clinical results or therapeutic pipeline exist as it is a service provider.